| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1048846695 |
| P356 | DOI | 10.1186/S13287-016-0341-0 |
| P8608 | Fatcat ID | release_7x4763za3rcmvkfgytpvrezzpu |
| P3181 | OpenCitations bibliographic resource ID | 1036520 |
| P932 | PMC publication ID | 4893234 |
| P698 | PubMed publication ID | 27259550 |
| P50 | author | Dwaipayan Sen | Q52322849 |
| P2093 | author name string | Abhishek Singh | |
| Aastha Singh | |||
| P2860 | cites work | Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient | Q21090134 |
| Inhibition of G9a Histone Methyltransferase Converts Bone Marrow Mesenchymal Stem Cells to Cardiac Competent Progenitors | Q22306435 | ||
| Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 | Q24304277 | ||
| Heart regeneration | Q24562846 | ||
| G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis | Q24673923 | ||
| Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow | Q79856815 | ||
| In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine | Q80725072 | ||
| Cardiac troponins | Q80795598 | ||
| Cardiovascular regenerative medicine: digging in for the long haul | Q80969416 | ||
| Prospective identification of myogenic endothelial cells in human skeletal muscle | Q80982228 | ||
| Mesenchymal stem cells or cardiac progenitors for cardiac repair? A comparative study | Q82038674 | ||
| Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction | Q82270561 | ||
| Improvement in cardiac function following transplantation of human umbilical cord matrix-derived mesenchymal cells | Q82515849 | ||
| [Effect of mesenchymal stem cells on cardiac function and restenosis of injured artery after myocardial infarction] | Q82556248 | ||
| Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy | Q42945928 | ||
| The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. | Q43010738 | ||
| Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes | Q43052164 | ||
| Differential effect of myocardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells | Q43121871 | ||
| Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 express | Q43141698 | ||
| Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia | Q43162637 | ||
| Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats | Q43169916 | ||
| A suspension induction for myocardial differentiation of rat mesenchymal stem cells on various extracellular matrix proteins. | Q43211701 | ||
| Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways | Q43606581 | ||
| Evaluation of an established pericardium patch for delivery of mesenchymal stem cells to cardiac tissue | Q43715374 | ||
| Mesenchymal stem cells overexpressing integrin-linked kinase attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions | Q43758357 | ||
| Comparison of cardiac stem cells and mesenchymal stem cells transplantation on the cardiac electrophysiology in rats with myocardial infarction | Q44069938 | ||
| Impact of repeated intravenous bone marrow mesenchymal stem cells infusion on myocardial collagen network remodeling in a rat model of doxorubicin-induced dilated cardiomyopathy | Q44081103 | ||
| Localization of mesenchymal stem cells grafted with a hyaluronan-based scaffold in the infarcted heart | Q44117813 | ||
| Early cardiac retention of administered stem cells determines clinical efficacy of cell therapy in patients with dilated cardiomyopathy | Q44426139 | ||
| MiR-499 induces cardiac differentiation of rat mesenchymal stem cells through wnt/β-catenin signaling pathway | Q44504125 | ||
| Tissue kallikrein-modified mesenchymal stem cells provide enhanced protection against ischemic cardiac injury after myocardial infarction | Q44724431 | ||
| Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects | Q44887109 | ||
| Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. | Q44960426 | ||
| Transplantation of mesenchymal stem cells with self-assembling polypeptide scaffolds is conducive to treating myocardial infarction in rats | Q45207014 | ||
| Human amniotic mesenchymal cells have some characteristics of cardiomyocytes | Q45309359 | ||
| Activity of mesenchymal stem cells in a nonperfused cardiac explant model | Q45820984 | ||
| Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats | Q45856161 | ||
| Amniotic mesenchymal stem cells with robust chemotactic properties are effective in the treatment of a myocardial infarction model | Q46041723 | ||
| MicroRNA-23a is involved in tumor necrosis factor-α induced apoptosis in mesenchymal stem cells and myocardial infarction | Q46075392 | ||
| Efficacy of subgroup mouse bone mesenchymal stem cells on mobilizing autologous cardiac stem cells and repairing ischemic myocardial tissue | Q46563182 | ||
| Study on culture and in vitro osteogenesis of blood-derived human mesenchymal stem cells | Q46676512 | ||
| Trimetazidine induces parkinsonism, gait disorders and tremor. | Q46789396 | ||
| Myocardium-targeted transplantation of mesenchymal stem cells by diagnostic ultrasound-mediated microbubble destruction improves cardiac function in myocardial infarction of New Zealand rabbits | Q47968678 | ||
| Mesenchymal stem cells enhanced cardiac nerve sprouting via nerve growth factor in a rat model of myocardial infarction | Q48026653 | ||
| Distinct patterns of histone modifications at cardiac-specific gene promoters between cardiac stem cells and mesenchymal stem cells | Q48033062 | ||
| Quantifying mesenchymal stem cells in the mononuclear cell fraction of bone marrow samples obtained for cell therapy. | Q48093656 | ||
| Magnetic resonance evaluation of transplanted mesenchymal stem cells after myocardial infarction in swine | Q50268532 | ||
| Ex vivo expansion of human mesenchymal stem cells on microcarriers | Q50279611 | ||
| MicroRNA-34a regulates cardiac ageing and function | Q50320387 | ||
| Adipose tissue derived mesenchymal stem cells for musculoskeletal repair in veterinary medicine | Q26822932 | ||
| Suicide gene reveals the myocardial neovascularization role of mesenchymal stem cells overexpressing CXCR4 (MSC(CXCR4)) | Q27316726 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Challenges in identifying the best source of stem cells for cardiac regeneration therapy | Q28083859 | ||
| Muscle satellite cells | Q28205273 | ||
| Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors | Q28256173 | ||
| MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction | Q28273466 | ||
| Fat tissue: an underappreciated source of stem cells for biotechnology | Q28298098 | ||
| miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling | Q28304542 | ||
| Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium | Q28576241 | ||
| Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model | Q28740879 | ||
| Vascular endothelial growth factor (VEGF) and its receptors | Q29615390 | ||
| RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial | Q29620044 | ||
| The relationship between the spleen colony-forming cell and the haemopoietic stem cell | Q29620090 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue | Q29620725 | ||
| Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. | Q30157916 | ||
| Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. | Q30167892 | ||
| Mesenchymal progenitor cells in human umbilical cord blood | Q30168979 | ||
| Ultrasound-Targeted Microbubble Destruction Improves the Migration and Homing of Mesenchymal Stem Cells after Myocardial Infarction by Upregulating SDF-1/CXCR4: A Pilot Study | Q30409340 | ||
| Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction | Q30496413 | ||
| Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation | Q30523741 | ||
| Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart | Q30528601 | ||
| MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart | Q30652787 | ||
| Autologous transplantation of bone marrow cells improves damaged heart function | Q30815113 | ||
| [Cardiovascular regenerative medicine at the crossroads. Clinical trials of cellular therapy must now be based on reliable experimental data from animals with characteristics similar to human's]. | Q31082580 | ||
| Right into the heart of microRNA-133a | Q33346399 | ||
| MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts | Q33580704 | ||
| Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction | Q33589174 | ||
| Islet-1 promotes the cardiac-specific differentiation of mesenchymal stem cells through the regulation of histone acetylation | Q33608677 | ||
| An experimental study on rabbit bone marrow mesenchymal stem cells double-labeled by PKH26 and 5-bromo-2'-deoxyuridine in vitro and application in cardiac patch | Q33652717 | ||
| Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET | Q33676193 | ||
| Extracellular matrix remodeling following myocardial infarction influences the therapeutic potential of mesenchymal stem cells | Q33746224 | ||
| Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction. | Q50458643 | ||
| Bosentan protects the spinal cord from ischemia reperfusion injury in rats through vascular endothelial growth factor receptors. | Q50461202 | ||
| Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model. | Q50462523 | ||
| Mesenchymal stem cells induce an inflammatory response after intravenous infusion. | Q50478967 | ||
| Differentiation of adipose tissue-derived mesenchymal stem cells into cardiomyocytes. | Q50486992 | ||
| [Effects of hRAMP1 modified mesenchymal stem cells on restenosis and heart function in rabbit model of carotid angioplasty and myocardial infarction]. | Q50487876 | ||
| [Effect of gene modified mesenchymal stem cells overexpression human receptor activity modified protein 1 on inflammation and cardiac repair in a rabbit model of myocardial infarction]. | Q50488111 | ||
| Cardiac Repair With a Novel Population of Mesenchymal Stem Cells Resident in the Human Heart. | Q50577371 | ||
| Myocardial structural protein expression in umbilical cord blood mesenchymal stem cells after myogenic induction. | Q50753352 | ||
| Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. | Q50790713 | ||
| bFGF binding cardiac extracellular matrix promotes the repair potential of bone marrow mesenchymal stem cells in a rabbit model for acute myocardial infarction. | Q50903293 | ||
| Myocardin-related transcription factor-A-overexpressing bone marrow stem cells protect cardiomyocytes and alleviate cardiac damage in a rat model of acute myocardial infarction. | Q50958017 | ||
| Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model. | Q51254265 | ||
| CXCR4 Antagonist TG-0054 Mobilizes Mesenchymal Stem Cells, Attenuates Inflammation, and Preserves Cardiac Systolic Function in a Porcine Model of Myocardial Infarction. | Q51724009 | ||
| Epicardium-derived cardiac mesenchymal stem cells: expanding the outer limit of heart repair. | Q51798304 | ||
| Regulating myogenic differentiation of mesenchymal stem cells using thermosensitive hydrogels. | Q51807649 | ||
| Nuclear cardiac troponin and tropomyosin are expressed early in cardiac differentiation of rat mesenchymal stem cells. | Q51810929 | ||
| Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. | Q51812638 | ||
| Signals through glycoprotein 130 regulate the endothelial differentiation of cardiac stem cells. | Q51824234 | ||
| Direct implantation versus platelet-rich fibrin-embedded adipose-derived mesenchymal stem cells in treating rat acute myocardial infarction. | Q53059882 | ||
| Injection of composite with bone marrow-derived mesenchymal stem cells and a novel synthetic hydrogel after myocardial infarction: a protective role in left ventricle function. | Q53061228 | ||
| Protective effects of Gingko biloba extract 761 on myocardial infarction via improving the viability of implanted mesenchymal stem cells in the rat heart. | Q53065864 | ||
| Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34⁺ cells in a rabbit model of myocardial infarction. | Q53085014 | ||
| Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction. | Q53096877 | ||
| In vivo differentiation of human amniotic epithelial cells into cardiomyocyte-like cells and cell transplantation effect on myocardial infarction in rats: comparison with cord blood and adipose tissue-derived mesenchymal stem cells. | Q53158324 | ||
| MicroRNA 16 enhances differentiation of human bone marrow mesenchymal stem cells in a cardiac niche toward myogenic phenotypes in vitro. | Q53164011 | ||
| Cardiac repair achieved by bone marrow mesenchymal stem cells/silk fibroin/hyaluronic acid patches in a rat of myocardial infarction model. | Q53169787 | ||
| [Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats]. | Q53235120 | ||
| A natural compound induced cardiogenic differentiation of endogenous MSCs for repair of infarcted heart | Q82588048 | ||
| Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia model | Q82830313 | ||
| Micropatterned matrix directs differentiation of human mesenchymal stem cells towards myocardial lineage | Q82903564 | ||
| miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 | Q83034995 | ||
| In vivo therapy of myocardial infarction with mesenchymal stem cells modified with prostaglandin I synthase gene improves cardiac performance in mice | Q83160114 | ||
| TRPC6, a potential novel target for enhancing cardiac repair of bone marrow mesenchymal stem cells | Q83275671 | ||
| Intracoronary delivery of mesenchymal stem cells reduces proarrhythmogenic risks in swine with myocardial infarction | Q83347349 | ||
| [Dural modulation effects of mesenchymal stem cells implantation on myocardial collagen remodeling in a rat model of myocardial infarction] | Q83414786 | ||
| Pretreatment of rat bone marrow mesenchymal stem cells with a combination of hypergravity and 5-azacytidine enhances therapeutic efficacy for myocardial infarction | Q83462883 | ||
| Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double | Q83582313 | ||
| Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function | Q83628797 | ||
| Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction | Q83653952 | ||
| Effects of bone marrow mesenchymal stem cells in a rat model of myocardial infarction | Q83748603 | ||
| Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism | Q84046166 | ||
| Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia | Q84141816 | ||
| Intravenous infusion of mesenchymal stem cells is associated with improved myocardial function during endotoxemia | Q84306542 | ||
| [Effects of the proliferation state of the endothelial progenitor cells preconditioned with salvianolic acid B and bone marrow mesenchymal stem cells transplanted in acute myocardial infarction rats] | Q84331900 | ||
| Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function | Q84511363 | ||
| Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesis | Q84557382 | ||
| Promigratory activity of oxytocin on umbilical cord blood-derived mesenchymal stem cells | Q84562408 | ||
| Stem cells transplantation combined with long-term mechanical circulatory support enhances myocardial viability in end-stage ischemic cardiomyopathy | Q84789011 | ||
| The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells | Q84857807 | ||
| Molecular advances shed light on cardiac myosin heavy chain expression in health and disease | Q84924156 | ||
| Mesenchymal stem cells stimulate protective genetic reprogramming of injured cardiac ventricular myocytes | Q85022401 | ||
| Transplantation of salvianolic acid B pretreated mesenchymal stem cells improves cardiac function in rats with myocardial infarction through angiogenesis and paracrine mechanisms | Q85251939 | ||
| [Beneficial effects of liver X receptor agonist on adipose-derived mesenchymal stem cells transplantation in mice with myocardial infarction] | Q85405094 | ||
| Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction | Q85708969 | ||
| Cell-based therapies for myocardial repair: emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart | Q85750974 | ||
| [Mesenchymal stem cells implantation increases the myofibroblasts congregating in infarct region in a rat model of myocardial infarction] | Q86015581 | ||
| Crosstalk of mesenchymal stem cells and macrophages promotes cardiac muscle repair | Q86151874 | ||
| Engraftment patterns of human adult mesenchymal stem cells expose electrotonic and paracrine proarrhythmic mechanisms in myocardial cell cultures | Q86159146 | ||
| A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction | Q86733086 | ||
| Timing of transplantation of autologous bone marrow derived mesenchymal stem cells for treating myocardial infarction | Q87107690 | ||
| Macrophages regulate renal fibrosis through modulating TGFβ superfamily signaling | Q88080852 | ||
| Role of WNT/β-catenin signaling in rejuvenating myogenic differentiation of aged mesenchymal stem cells from cardiac patients | Q95423512 | ||
| Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction | Q95430666 | ||
| Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells: a novel treatment in patients of acute myocardial infarction | Q95505111 | ||
| Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. | Q53328521 | ||
| Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction. | Q53379079 | ||
| Priming of mesenchymal stem cells with oxytocin enhances the cardiac repair in ischemia/reperfusion injury. | Q53407725 | ||
| Combination of retinoic acid, dimethyl sulfoxide and 5-azacytidine promotes cardiac differentiation of human fetal liver-derived mesenchymal stem cells. | Q53469182 | ||
| Functional integration of quantum dot labeled mesenchymal stem cells in a cardiac microenvironment. | Q53478486 | ||
| Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction. | Q53542332 | ||
| Mesenchymal stem cells promote cardiac muscle repair via enhanced neovascularization. | Q53585286 | ||
| Umbilical-cord-blood-derived mesenchymal stem cells seeded onto fibronectin-immobilized polycaprolactone nanofiber improve cardiac function. | Q53592436 | ||
| Cellular repressor of E1A-stimulated gene overexpression in bone mesenchymal stem cells protects against rat myocardial infarction. | Q53617595 | ||
| Co-treating mesenchymal stem cells with IL‑1β and TNF-α increases VCAM-1 expression and improves post-ischemic myocardial function. | Q54208177 | ||
| Mesenchymal stem cells overexpressing integrin-linked kinase attenuate left ventricular remodeling and improve cardiac function after myocardial infarction. | Q54329066 | ||
| Mesenchymal stem cells enhance the differentiation of c-kit+ cardiac stem cells. | Q54332276 | ||
| Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats. | Q54333103 | ||
| Effects of mesenchymal stem cells on matrix metalloproteinase synthesis in cardiac fibroblasts. | Q54353050 | ||
| Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. | Q54441341 | ||
| Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. | Q54473910 | ||
| Pretreating mesenchymal stem cells with interleukin-1β and transforming growth factor-β synergistically increases vascular endothelial growth factor production and improves mesenchymal stem cell-mediated myocardial protection after acute ischemia. | Q54549578 | ||
| Transplantation of induced bone marrow mesenchymal stem cells improves the cardiac function of rabbits with dilated cardiomyopathy via upregulation of vascular endothelial growth factor and its receptors. | Q54571678 | ||
| High-efficiency matrix modulus-induced cardiac differentiation of human mesenchymal stem cells inside a thermosensitive hydrogel | Q57218244 | ||
| Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study | Q57254134 | ||
| A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow | Q57601743 | ||
| Human mesenchymal stem cells express a myofibroblastic phenotype in vitro: comparison to human cardiac myofibroblasts | Q58047134 | ||
| Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion | Q58109706 | ||
| Mesenchymal Stem Cells Provide Better Results Than Hematopoietic Precursors for the Treatment of Myocardial Infarction | Q59938198 | ||
| Hypoxia-Inducible Factor 1 Alpha Contributes to Cardiac Healing in Mesenchymal Stem Cells-Mediated Cardiac Repair | Q60394825 | ||
| Spontaneous Malignant Transformation of Human Mesenchymal Stem Cells Reflects Cross-Contamination: Putting the Research Field on Track - Letter | Q61039117 | ||
| Transplantation of Mesenchymal Stem Cells Exerts a Greater Long-Term Effect than Bone Marrow Mononuclear Cells in a Chronic Myocardial Infarction Model in Rat | Q62980583 | ||
| Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not | Q73267825 | ||
| Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy | Q73316865 | ||
| Hematopoietic stem cells | Q73977336 | ||
| Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood | Q74622924 | ||
| Mesenchymal stem cells | Q75301443 | ||
| Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord | Q78799982 | ||
| Isolation of multipotent mesenchymal stem cells from umbilical cord blood | Q79202796 | ||
| Expression of Myocardial Specificity Markers MEF-2C and Cx43 in Rat Bone Marrow-derived Mesenchymal Stem Cells Induced by Electrical Stimulation In Vitro | Q35815068 | ||
| Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction | Q35824554 | ||
| Adipose-derived mesenchymal stem cells embedded in platelet-rich fibrin scaffolds promote angiogenesis, preserve heart function, and reduce left ventricular remodeling in rat acute myocardial infarction | Q35826439 | ||
| Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study. | Q35829154 | ||
| Human mesenchymal stromal cells improve scar thickness without enhancing cardiac function in a chronic ischaemic heart failure model | Q35896781 | ||
| Cardiac regeneration | Q35928368 | ||
| Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4. | Q35941299 | ||
| Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats | Q35987027 | ||
| Regeneration of the heart | Q36038854 | ||
| Hypoxic preconditioning protects against ischemic brain injury | Q36045209 | ||
| Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction | Q36085396 | ||
| Cardiac Stem Cell Hybrids Enhance Myocardial Repair. | Q36094922 | ||
| Myocyte-depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells | Q36095590 | ||
| Stem cells of the alveolar epithelium | Q36197188 | ||
| Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial Infarction | Q36214819 | ||
| Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue | Q36237933 | ||
| Effects of Intracoronary Administration of Autologous Adipose Tissue-Derived Stem Cells on Acute Myocardial Infarction in a Porcine Model | Q36240131 | ||
| Endothelial cells and VEGF in vascular development | Q36342350 | ||
| Tailoring material properties of cardiac matrix hydrogels to induce endothelial differentiation of human mesenchymal stem cells | Q36384613 | ||
| Repairing chronic myocardial infarction with autologous mesenchymal stem cells engineered tissue in rat promotes angiogenesis and limits ventricular remodeling | Q36521778 | ||
| Fetal cardiac mesenchymal stem cells express embryonal markers and exhibit differentiation into cells of all three germ layers | Q36568629 | ||
| Mesenchymal stem cells improve cardiac conduction by upregulation of connexin 43 through paracrine signaling | Q36593007 | ||
| Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial | Q36603453 | ||
| Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction | Q36630155 | ||
| A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction | Q36632891 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| Impaired cardioprotective function of transplantation of mesenchymal stem cells from patients with diabetes mellitus to rats with experimentally induced myocardial infarction | Q36689801 | ||
| Cord lining-mesenchymal stem cells graft supplemented with an omental flap induces myocardial revascularization and ameliorates cardiac dysfunction in a rat model of chronic ischemic heart failure | Q36801683 | ||
| Monocyte chemotactic protein-1 promotes the myocardial homing of mesenchymal stem cells in dilated cardiomyopathy | Q36820558 | ||
| Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair | Q36861491 | ||
| Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction | Q36881332 | ||
| Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury | Q36909590 | ||
| TGF-beta and BMP7 interactions in tumour progression and bone metastasis | Q37002892 | ||
| The identification of novel targets of miR-16 and characterization of their biological functions in cancer cells | Q37115691 | ||
| Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue | Q37132476 | ||
| Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up | Q37216076 | ||
| Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen | Q37276182 | ||
| Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction | Q37294044 | ||
| Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction | Q37353891 | ||
| Thymosin β4 increases the potency of transplanted mesenchymal stem cells for myocardial repair | Q37457917 | ||
| A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction | Q37473636 | ||
| Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. | Q37512295 | ||
| The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches | Q37583936 | ||
| Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent | Q37642556 | ||
| Cardiac fibroblast-derived 3D extracellular matrix seeded with mesenchymal stem cells as a novel device to transfer cells to the ischemic myocardium | Q37661493 | ||
| Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy | Q37687409 | ||
| Surgical models for cardiac regeneration in neonatal mice | Q37688522 | ||
| Mesenchymal stem cells: a new trend for cell therapy | Q37729093 | ||
| Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices | Q37772818 | ||
| Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche | Q37777514 | ||
| The role of microRNA in modulating myocardial ischemia-reperfusion injury | Q37801505 | ||
| Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. | Q37827159 | ||
| Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. | Q37875244 | ||
| SDF-1 in myocardial repair | Q38016714 | ||
| Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis | Q38021450 | ||
| Current status of myocardial regeneration therapy | Q38058287 | ||
| Function and fate of myofibroblasts after myocardial infarction | Q38085345 | ||
| JAK-STAT signaling in cardiomyogenesis of cardiac stem cells | Q38140885 | ||
| Cardiac regeneration: current therapies-future concepts | Q38164335 | ||
| Hydrogel based injectable scaffolds for cardiac tissue regeneration | Q38177131 | ||
| Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility | Q38207604 | ||
| Mesenchymal stem cells for treatment of myocardial infarction. | Q38214090 | ||
| Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications | Q38261365 | ||
| Common expression of stemness molecular markers and early cardiac transcription factors in human Wharton's jelly-derived mesenchymal stem cells and embryonic stem cells | Q38317834 | ||
| Stem cells: the generation and maintenance of cellular diversity | Q38334445 | ||
| The potential and challenges of using stem cells for cardiovascular repair and regeneration | Q38340609 | ||
| Primary cardiac sarcomas may develop from resident or bone marrow-derived mesenchymal stem cells: use of immunohistochemistry including CD44 and octamer binding protein 3/4. | Q38402248 | ||
| Superior therapeutic potential of young bone marrow mesenchymal stem cells by direct intramyocardial delivery in aged recipients with acute myocardial infarction: in vitro and in vivo investigation. | Q35127582 | ||
| Downregulation of HDAC1 is involved in the cardiomyocyte differentiation from mesenchymal stem cells in a myocardial microenvironment | Q35137443 | ||
| Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway | Q35163294 | ||
| Mesenchymal stem cells from fetal heart attenuate myocardial injury after infarction: an in vivo serial pinhole gated SPECT-CT study in rats | Q35196281 | ||
| The Bcl-2-regulated apoptotic pathway | Q35218049 | ||
| Synergistic effect of angiotensin II on vascular endothelial growth factor-A-mediated differentiation of bone marrow-derived mesenchymal stem cells into endothelial cells | Q35562287 | ||
| Exosomes Secreted from CXCR4 Overexpressing Mesenchymal Stem Cells Promote Cardioprotection via Akt Signaling Pathway following Myocardial Infarction | Q35621007 | ||
| 5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase | Q35632731 | ||
| N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction | Q35665230 | ||
| Plasticity of adult stem cells | Q35684656 | ||
| Mesenchymal stem cells: clinical applications and biological characterization. | Q35686355 | ||
| Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial | Q35688535 | ||
| Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Acute Myocardial Ischemic Injury | Q35708579 | ||
| Exogenous Nkx2.5- or GATA-4-transfected rabbit bone marrow mesenchymal stem cells and myocardial cell co-culture on the treatment of myocardial infarction in rabbits | Q35727809 | ||
| Atherogenic Cytokines Regulate VEGF-A-Induced Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells into Endothelial Cells | Q35729854 | ||
| Involvement of miR-34c in high glucose-insulted mesenchymal stem cells leads to inefficient therapeutic effect on myocardial infarction | Q35732792 | ||
| Prostaglandin E₁ protects bone marrow-derived mesenchymal stem cells against serum deprivation-induced apoptosis | Q35739823 | ||
| Engineered myocardial tissues constructed in vivo using cardiomyocyte-like cells derived from bone marrow mesenchymal stem cells in rats | Q35747710 | ||
| Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation | Q35769073 | ||
| Dual isotope simultaneous imaging to evaluate the effects of intracoronary bone marrow-derived mesenchymal stem cells on perfusion and metabolism in canines with acute myocardial infarction | Q35802937 | ||
| Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction | Q33746524 | ||
| Mesenchymal stem cells with overexpression of midkine enhance cell survival and attenuate cardiac dysfunction in a rat model of myocardial infarction | Q33746629 | ||
| Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation | Q33757338 | ||
| Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction | Q33823473 | ||
| Isolation of primary and immortalized CD34-hematopoietic and mesenchymal stem cells from various sources | Q33830884 | ||
| Elevated miR-499 levels blunt the cardiac stress response | Q33900451 | ||
| An improved transplantation strategy for mouse mesenchymal stem cells in an acute myocardial infarction model | Q33940671 | ||
| Postinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-alpha improves acute myocardial function. | Q33994997 | ||
| Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts | Q34023300 | ||
| The stimulation of the cardiac differentiation of mesenchymal stem cells in tissue constructs that mimic myocardium structure and biomechanics. | Q34077880 | ||
| The nuclear factor NF-kappaB pathway in inflammation | Q34114512 | ||
| Protective effects of trimetazidine on bone marrow mesenchymal stem cells viability in an ex vivo model of hypoxia and in vivo model of locally myocardial ischemia | Q34142745 | ||
| Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathies | Q34152221 | ||
| Status of umbilical cord blood transplantation in the year 2001. | Q34263277 | ||
| Mesenchymal stem cells | Q34275859 | ||
| Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair | Q34357753 | ||
| In vivo magnetic resonance imaging tracking of transplanted superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells in rats with myocardial infarction | Q34540793 | ||
| Stem cells--a clinical update. | Q34565718 | ||
| Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf-2 signaling pathways | Q34579503 | ||
| The relative contribution of paracine effect versus direct differentiation on adipose-derived stem cell transplantation mediated cardiac repair | Q34634535 | ||
| Mesenchymal stem cells and inflammatory cardiomyopathy: cardiac homing and beyond | Q34635689 | ||
| Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study | Q34637607 | ||
| Mesenchymal stem cell transformation and sarcoma genesis | Q34654560 | ||
| Muscle-derived stem cells | Q34658455 | ||
| Cardiogel: a nano-matrix scaffold with potential application in cardiac regeneration using mesenchymal stem cells | Q34733499 | ||
| Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury | Q34757237 | ||
| Risk factors in the development of stem cell therapy | Q34761224 | ||
| Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase. | Q34761461 | ||
| Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart | Q34785250 | ||
| Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction | Q34956358 | ||
| TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth | Q35009619 | ||
| Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells | Q35011205 | ||
| Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. | Q35030040 | ||
| Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage | Q35087969 | ||
| Placental-derived stem cells: Culture, differentiation and challenges | Q38510227 | ||
| MicroRNAs as a diagnostic tool for heart failure and atrial fibrillation | Q38725132 | ||
| Growth factors mediated differentiation of mesenchymal stem cells to cardiac polymicrotissue using hanging drop and bioreactor. | Q39078463 | ||
| Bone marrow mesenchymal stem cells improve myocardial function in a swine model of acute myocardial infarction | Q39154134 | ||
| Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model | Q39298884 | ||
| Immortalization of bone marrow-derived porcine mesenchymal stem cells and their differentiation into cells expressing cardiac phenotypic markers. | Q39429314 | ||
| Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction | Q39482040 | ||
| Human cardiac explant-conditioned medium: soluble factors and cardiomyogenic effect on mesenchymal stem cells. | Q39853470 | ||
| Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfunction and survival in a rat myocardial infarction model | Q39961298 | ||
| microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart | Q40036277 | ||
| Ca2+ and the contractile proteins | Q40117020 | ||
| Hypoxic adipose mesenchymal stem cells derived conditioned medium protects myocardial infarct in rat. | Q40242692 | ||
| let-7b suppresses apoptosis and autophagy of human mesenchymal stem cells transplanted into ischemia/reperfusion injured heart 7by targeting caspase-3. | Q40618751 | ||
| Placental Growth Factor Promotes Cardiac Muscle Repair via Enhanced Neovascularization | Q40821869 | ||
| Preclinical evaluation of the immunomodulatory properties of cardiac adipose tissue progenitor cells using umbilical cord blood mesenchymal stem cells: a direct comparative study | Q41091183 | ||
| Tissue inhibitor of matrix metalloproteinase-3 or vascular endothelial growth factor transfection of aged human mesenchymal stem cells enhances cell therapy after myocardial infarction | Q41672067 | ||
| Mesenchymal Progenitor Cells: Tissue Origin, Isolation and Culture | Q41899828 | ||
| Cardiac specific gene expression changes in long term culture of murine mesenchymal stem cells | Q41959817 | ||
| Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction. | Q42015303 | ||
| Functional properties of bone marrow derived multipotent mesenchymal stromal cells are altered in heart failure patients, and could be corrected by adjustment of expansion strategies | Q42017721 | ||
| In vitro differentiation of bone marrow derived porcine mesenchymal stem cells to endothelial cells | Q42139577 | ||
| Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling | Q42226249 | ||
| Ischemic cardiac tissue conditioned media induced differentiation of human mesenchymal stem cells into early stage cardiomyocytes. | Q42322591 | ||
| Effects of scaffold material used in cardiovascular surgery on mesenchymal stem cells and cardiac progenitor cells | Q42408076 | ||
| Controlled delivery of stromal derived factor-1α from poly lactic-co-glycolic acid core-shell particles to recruit mesenchymal stem cells for cardiac regeneration | Q42475997 | ||
| GMP-adapted overexpression of CXCR4 in human mesenchymal stem cells for cardiac repair. | Q42507583 | ||
| Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial inject | Q42554253 | ||
| Induced bone marrow mesenchymal stem cells improve cardiac performance of infarcted rat hearts | Q42604737 | ||
| Biomimetic platforms for human stem cell research | Q42650130 | ||
| Transplantation of SIRT1-engineered aged mesenchymal stem cells improves cardiac function in a rat myocardial infarction model | Q42672566 | ||
| The mechanism underlying the differentiation of human umbilical cord-derived mesenchymal stem cells into myocardial cells induced by 5-azacytidine | Q42715705 | ||
| Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair | Q42794686 | ||
| Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction | Q42827144 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell | Q7868 |
| regeneration | Q193119 | ||
| mesenchymal stem cell | Q1922379 | ||
| myocardial infarction | Q12152 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 82 | |
| P577 | publication date | 2016-06-04 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015) | |
| P478 | volume | 7 |
| Q90573402 | 3D bioprinting for cardiovascular regeneration and pharmacology |
| Q52584392 | Adipose tissue stem cells in regenerative medicine. |
| Q47096418 | Aspirin inhibits the proliferation of synovium-derived mesenchymal stem cells by arresting the cell cycle in the G0/G1 phase |
| Q92876073 | Bioprinting Vasculature: Materials, Cells and Emergent Techniques |
| Q39017865 | Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells |
| Q92997198 | Cardiac Nestin+ Mesenchymal Stromal Cells Enhance Healing of Ischemic Heart through Periostin-Mediated M2 Macrophage Polarization |
| Q55689725 | Cardiomyogenic Heterogeneity of Clonal Subpopulations of Human Bone Marrow Mesenchymal Stem Cells. |
| Q59793899 | Cell surface engineering and application in cell delivery to heart diseases |
| Q39410733 | Cellular mechanisms underlying cardiac engraftment of stem cells. |
| Q91949725 | Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review |
| Q90079825 | Characterization of the immunomodulatory properties of alveolar bone-derived mesenchymal stem cells |
| Q48522708 | Co-cultured the MSCs and cardiomyocytes can promote the growth of cardiomyocytes. |
| Q64277124 | Concise Review: Therapeutic Potential of the Mesenchymal Stem Cell Derived Secretome and Extracellular Vesicles for Radiation-Induced Lung Injury: Progress and Hypotheses |
| Q47744943 | Differentiation of mesenchymal stem cells from human amniotic fluid to cardiomyocyte‑like cells. |
| Q33654961 | Differentiation of mesenchymal stem cells into cardiomyocytes is regulated by miRNA-1-2 via WNT signaling pathway |
| Q47095240 | Effects of Neuropeptide Y on Stem Cells and Their Potential Applications in Disease Therapy. |
| Q47699787 | Engineering of cell-laden gelatin-based microgels for cell delivery and immobilization in regenerative therapies |
| Q47137450 | Evaluating the biological risk of functionalized multiwalled carbon nanotubes and functionalized oxygen-doped multiwalled carbon nanotubes as possible toxic, carcinogenic, and embryotoxic agents. |
| Q49183974 | Extracellular vesicles and cardiovascular disease therapy |
| Q38710399 | Focal adhesion kinase signaling regulates anti-inflammatory function of bone marrow mesenchymal stromal cells induced by biomechanical force |
| Q47763451 | Functional Role of Cardiovascular Exosomes in Myocardial Injury and Atherosclerosis |
| Q46360944 | Functional and Structural Assessment of the Effect of Human Umbilical Cord Blood Mesenchymal Stem Cells in Doxorubicin-Induced Cardiotoxicity |
| Q64084376 | Hypoxia-Regulated miRNAs in Human Mesenchymal Stem Cells: Exploring the Regulatory Effects in Ischemic Disorders |
| Q60048546 | Hypoxic Preconditioned Mesenchymal Stromal Cell Therapy in a Rat Model of Renal Ischemia-reperfusion Injury: Development of Optimal Protocol to Potentiate Therapeutic Efficacy |
| Q58726387 | Impact of Biomaterials on Differentiation and Reprogramming Approaches for the Generation of Functional Cardiomyocytes |
| Q91878243 | In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair |
| Q90347777 | Inducing Endogenous Cardiac Regeneration: Can Biomaterials Connect the Dots? |
| Q38664925 | Influence of patient related factors on number of mesenchymal stromal cells reached after in vitro culture expansion for clinical treatment. |
| Q88589106 | Injectable Hydrogels for Cardiac Tissue Engineering |
| Q92764725 | Mechanism of 17β-estradiol stimulated integration of human mesenchymal stem cells in heart tissue |
| Q41547811 | Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells |
| Q90056972 | Mesenchymal Stem Cells Beyond Regenerative Medicine |
| Q55649548 | Midterm outcomes of transmyocardial laser revascularization with intramyocardial injection of adipose derived stromal cells for severe refractory angina. |
| Q28078093 | New Treatment Strategies for Alcohol-Induced Heart Damage |
| Q90267302 | Non-inferiority of microencapsulated mesenchymal stem cells to free cells in cardiac repair after myocardial infarction: A rationale for using paracrine factor(s) instead of cells |
| Q47101037 | OCT4 expression mediates partial cardiomyocyte reprogramming of mesenchymal stromal cells |
| Q41391958 | Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis. |
| Q91708011 | Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells |
| Q92129037 | Progenitor Cells Derived from Drain Waste Product of Open-Heart Surgery in Children |
| Q52657125 | Recent Progress in Stem Cell Modification for Cardiac Regeneration. |
| Q90029075 | Recent advances in 3D printing: vascular network for tissue and organ regeneration |
| Q47129410 | Stem Cells from Dental Pulp: What Epigenetics Can Do with Your Tooth |
| Q98291518 | The "Salmon Spirit" of translational medical research |
| Q52322793 | The Delta Opioid Peptide DADLE Represses Hypoxia-Reperfusion Mimicked Stress Mediated Apoptotic Cell Death in Human Mesenchymal Stem Cells in Part by Downregulating the Unfolded Protein Response and ROS along with Enhanced Anti-Inflammatory Effect. |
| Q89879900 | The Effects of Ethanol on the Heart: Alcoholic Cardiomyopathy |
| Q46302230 | The current status and future of cardiac stem/progenitor cell therapy for congenital heart defects from diabetic pregnancy |
| Q64093640 | The effects of graphene and mesenchymal stem cells in cutaneous wound healing and their putative action mechanism |
| Q88159540 | The influence of hypoxia and IFN-γ on the proteome and metabolome of therapeutic mesenchymal stem cells |
| Q64283200 | Transcriptomes of human mesenchymal cells isolated from the right ventricle and epicardial fat differ strikingly both directly after isolation and long-term culture |
Search more.